NSE filing, NSE: BAJAJFINSV. Summary written from the filing by ALFA Finder's alert engine.
Bajaj Finserv Ltd: key numbers
- Share price
- ₹1,652.40
- Market cap
- ₹2,64,475 Cr
- Revenue (annual)
- ₹1,50,504 Cr
- Net profit (annual)
- ₹9,801 Cr
- P/E (TTM)
- 26.1×Sector 21.4×
- Promoter holding
- 58.65%-0.06% QoQ
- FII holding
- 8.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bajaj Finserv Ltd
All →Bajaj Finserv Management Change
Deepak Reddy appointed CEO Designate of Bajaj General Insurance, a material Bajaj Finserv subsidiary. He assumes MD & CEO role effective April 2027, subject to IRDAI approval.
Bajaj Finserv Merger & Restructuring Worth ₹1 Cr
Bajaj Finserv Limited incorporated a wholly owned subsidiary, Bajaj Reinsurance Limited, for reinsurance business. The investment for this subscription amounts to Rs. 1 Crore.
- Value
- ₹1.00 Cr
Bajaj Finserv Other Announcement
Bajaj Finserv Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulation 31(1)(b).
Bajaj Finserv Business Update
Bajaj Finserv released monthly premium and new business performance figures for its unlisted insurance subsidiaries, Bajaj General and Bajaj Life, for September 2026.
Bajaj Finserv Board Meeting Date
Bajaj Finserv Ltd scheduled a board meeting for November 3, 2026, to consider and approve its unaudited standalone and consolidated financial results.
Bajaj Finserv Acquisition Worth ₹5,800 Cr
Bajaj Finserv will subscribe to convertible warrants of its subsidiary, Bajaj Finance Ltd, for a total cash consideration of Rs. 5,800 Crore.
- Value
- ₹5,800 Cr
- From
- Bajaj Finance Limited
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.